W1M Asset Management Ltd Invests $30.84 Million in Danaher Corporation $DHR

Key Points

• W1M Asset Management purchased 42,845 Danaher shares worth approximately $30.84 million, while institutional investors and hedge funds collectively own 79.05% of the stock.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $228.91, although several firms recently lowered their targets.
• Danaher beat quarterly earnings and revenue expectations, reporting $1.94 in EPS and $6.26 billion in revenue; revenue increased 5.5% year over year.

W1M Asset Management Ltd bought a new stake in Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor bought 42,845 shares of the conglomerate's stock, valued at approximately $30,839,000.

Several other hedge funds have also bought and sold shares of DHR. BlackRock Inc. acquired a new position in Danaher during the second quarter worth approximately $10,492,520,000. Norges Bank acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $2,177,106,000. Generation Investment Management LLP bought a new position in shares of Danaher during the 2nd quarter worth approximately $1,287,949,000. Flossbach Von Storch SE acquired a new position in shares of Danaher during the 2nd quarter worth approximately $747,260,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Danaher during the 2nd quarter worth approximately $712,875,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the company. Evercore reaffirmed an "outperform" rating and set a $230.00 price target on shares of Danaher in a report on Monday, July 6th. TD Cowen dropped their price objective on shares of Danaher from $240.00 to $236.00 and set a "buy" rating on the stock in a research report on Wednesday, July 22nd. Stifel Nicolaus cut their target price on shares of Danaher from $260.00 to $220.00 and set a "buy" rating for the company in a research note on Wednesday, July 22nd. Guggenheim reduced their target price on shares of Danaher from $235.00 to $200.00 and set a "buy" rating for the company in a report on Wednesday, July 22nd. Finally, Weiss Ratings raised shares of Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, Danaher currently has a consensus rating of "Moderate Buy" and a consensus price target of $228.91.

Danaher Stock Up 1.6%

DHR opened at $219.42 on Friday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The company has a market capitalization of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. The stock has a fifty day moving average of $195.80 and a 200-day moving average of $192.61.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the prior year, the company posted $0.77 earnings per share. Danaher's revenue was up 5.5% compared to the same quarter last year. On average, equities analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source